{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T12:23:17Z","timestamp":1772626997518,"version":"3.50.1"},"reference-count":25,"publisher":"American Society for Microbiology","issue":"6","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2007,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Three commonly used<jats:italic>Mycobacterium bovis<\/jats:italic>BCG vaccine strains elicited different magnitudes of T-cell activation and gamma interferon production in vitro in healthy BCG-vaccinated individuals. Glaxo 1077 exhibited the greatest stimulatory capacity, followed by Pasteur 1173 and then Danish 1331. These differences may affect in vitro stimulation and vaccination-induced immunogenicity.<\/jats:p>","DOI":"10.1128\/iai.01611-06","type":"journal-article","created":{"date-parts":[[2007,3,27]],"date-time":"2007-03-27T01:13:09Z","timestamp":1174957989000},"page":"3197-3201","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":16,"title":["Strain-Dependent Variation in<i>Mycobacterium bovis<\/i>BCG-Induced Human T-Cell Activation and Gamma Interferon Production In Vitro"],"prefix":"10.1128","volume":"75","author":[{"given":"Ana M.","family":"Aguirre-Blanco","sequence":"first","affiliation":[{"name":"Department of Infectious and Tropical Diseases, London School of Hygiene &amp; Tropical Medicine, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline T.","family":"Lukey","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline R&amp;D, Stevenage, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline M.","family":"Cliff","sequence":"additional","affiliation":[{"name":"Department of Infectious and Tropical Diseases, London School of Hygiene &amp; Tropical Medicine, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hazel M.","family":"Dockrell","sequence":"additional","affiliation":[{"name":"Department of Infectious and Tropical Diseases, London School of Hygiene &amp; Tropical Medicine, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"3047","volume":"132","year":"1986","unstructured":"Abou-Zeid, C., I. Smith, J. Grange, J. Steele, and G. Rook. 1986. Subdivision of daughter strains of bacille Calmette-Guerin (BCG) according to secreted protein patterns. J. Gen. Microbiol.132:3047-3053.","journal-title":"J. Gen. Microbiol."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00369-8"},{"key":"e_1_3_2_4_2","first-page":"141","volume":"180","year":"2002","unstructured":"Behr, M. A. 2002. BCG\u2014different strains, different vaccines? Lancet Infect. Dis.180:141-149.","journal-title":"Lancet Infect. Dis."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/38151"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)00277-1"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.284.5419.1520"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1086\/314072"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"372","DOI":"10.4049\/jimmunol.162.1.372","volume":"162","year":"1999","unstructured":"Canaday, D. H., C. Ziebold, E. H. Noss, K. A. Chervenak, C. V. Harding, and W. H. Boom. 1999. Activation of human CD8+ alpha beta TCR+ cells by Mycobacterium tuberculosis via an alternate class I MHC antigen-processing pathway. J. Immunol.162:372-379.","journal-title":"J. Immunol."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0041-3879(85)90064-9"},{"key":"e_1_3_2_11_2","first-page":"419","volume":"104","year":"1996","unstructured":"Esin, S., G. Batoni, G. Kallenius, H. Gaines, M. Campa, S. B. Svenson, R. Andersson, and H. Wigzell. 1996. Proliferation of distinct human T cell subsets in response to live, killed or soluble extracts of Mycobacterium tuberculosis and Myco. avium. Clin. Exp. Immunol. 104:419-425.","journal-title":"Proliferation of distinct human T cell subsets in response to live"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)92348-9"},{"key":"e_1_3_2_13_2","unstructured":"Issues relating to the use of BCG in immunization programmes. 1999"},{"key":"e_1_3_2_14_2","first-page":"125","volume":"134","year":"1983","unstructured":"Gheorghiu, M., and P. H. Lagrange. 1983. Viability, heat stability and immunogenicity of four BCG vaccines prepared from four different BCG strains. Ann. Immunol. (Paris) 134C:125-147.","journal-title":"Ann. Immunol."},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.4.2035-2039.1999"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.04.037"},{"key":"e_1_3_2_17_2","first-page":"37","volume":"58","year":"1986","unstructured":"Grange, J. M., and J. A. Gibson. 1986. Strain to strain variation in the immunogenicity of BCG. Dev. Biol. Stand.58:37-41.","journal-title":"Dev. Biol. Stand."},{"key":"e_1_3_2_18_2","first-page":"49","volume":"47","year":"1972","unstructured":"Horwitz, O., and K. Bunch-Christensen. 1972. Correlation between tuberculin sensitivity after 2 months and 5 years among BCG vaccinated subjects. Bull. W. H. O. 47:49-58.","journal-title":"Bull"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.64.1.1-9.1996"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.187.10.1633"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.61.5.1730-1734.1993"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.39.2.540-545.1983"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(03)00484-5"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.10.5223-5230.1999"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1996.512590.x"},{"key":"e_1_3_2_26_2","unstructured":"Vaccine-preventable diseases: monitoring system global summary 2004"}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.01611-06","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.01611-06","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T11:20:15Z","timestamp":1707736815000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.01611-06"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["10.1128\/IAI.01611-06"],"URL":"https:\/\/doi.org\/10.1128\/iai.01611-06","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6]]},"assertion":[{"value":"2006-10-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2007-03-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2007-06-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}